Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Bullboard - Stock Discussion Forum SQI Diagnostics Inc SQIDF


Primary Symbol: V.SQD.H

SQI Diagnostics Inc. is a Canada-based company that is focused on lung health. The Company is engaged in the development and manufacturing of respiratory health and precision medicine tests that run on its fully automated systems. Its clinical solutions include Rapid Acute Lung Injury Diagnostic (RALI-Dx), lung transplant diagnostics, COVID-19 testing and surveillance testing solutions. Its... see more

TSXV:SQD.H - Post Discussion

SQI Diagnostics Inc > Azova "changing the world". SQI will too.
View:
Post by FactFinder1994 on May 16, 2023 4:25pm

Azova "changing the world". SQI will too.

Cheryl Lee Eberting, M.D.
CEO and Founder of AZOVA

Hello everyone. Today I want to share a big milestone for my team AZOVA. For the past nine+ years we have worked heads down on our integrated digital health #employeebenefits platform and our integrated and connected nationwide #healthcare provider networks.

People told me I was crazy when I started AZOVA. They told me it would never work. They said that healthcare is too hard to change. They said stay narrow. Be a single solution. Focus on one thing—that really is good advice in almost EVERY other business venture. However, the problems with our healthcare system will never be fixed with a narrow, single point solution. Healthcare involves so many entities, so many systems, so many services, so many different people, and has so many misaligned incentives. At AZOVA we have a master strategy; we aren’t going to fix our healthcare system. Instead, we are building a new one. We are building a healthcare system that actually works for the patient.

During the pandemic, we stretched to become one of the largest COVID test proctoring and COVID test and vaccination records management systems in the world. We partnered with the world’s largest retailers, global airline partners, government entities such as the state of Hawaii, and managed laboratory testing networks in 11 countries. 

Today, nearly ONE MILLION patients access their healthcare online through AZOVA. In all 50 states we are now providing primary care, pediatrics, psychiatry, therapy, dermatology, men’s health, women’s health and more. Any qualified provider can join an AZOVA network and can work from anywhere to deliver their services to patients who need them. The AZOVA team is working to build the healthcare system that we all want–a system that is built around the patient, for the patient, and which is everything about the patient–oh, and did I mention, a healthcare system that is straightforward and affordable. See ya later ridiculously complicated and expensive healthcare!

Thank you everyone AZOVA for your very important part in changing the world and making a difference in the lives of our patients and customers. Thank you to the EY team for this honor to be named as a finalist in the Ernst and Young Entrepreneur of the Year program. This has always been a personal goal of mine, but now I must carry on and get back to work–we’ve got a healthcare system to build for all of us. #eoy
Be the first to comment on this post
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities